MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Anxiety"

  • MDS Virtual Congress 2020

    The impact of anxiety on social functioning in Parkinson’s disease

    K. Perepezko, J. Hinkle, K. Mills, G. Pontone (Baltimore, MD, USA)

    Objective: To identify factors associated with social functioning in Parkinson’s disease (PD). Background: PD frequently impedes activities of daily living including social functioning [1,2]. Impairments…
  • MDS Virtual Congress 2020

    In vivo markers of anxiety in drug-naïve Parkinson’s disease

    H. Wilson, E. de Natale, M. Politis (London, United Kingdom)

    Objective: To investigate imaging and CSF markers of disease pathology associated with anxiety in drug-naïve idiopathic Parkinson’s disease (PD) patients. Background: Anxiety is a frequent…
  • MDS Virtual Congress 2020

    Higher adherence to MIND diet associated with later onset of Parkinson’s disease

    A. Metcalfe-Roach, M. Cirstea, A. Yu, E. Golz, K. Sundvick, D. Kliger, B. Finlay, S. Appel-Cresswell (Vancouver, BC, Canada)

    Objective: This study evaluated the impact of MIND diet adherence on Parkinson’s disease (PD) onset and related symptoms. Background: PD is a common neurodegenerative disease…
  • MDS Virtual Congress 2020

    CSF inflammatory cytokines and correlation with clinical features in early, untreated PD patients

    E. Olivola, M. Stampanoni Bassi, L. Gilio, C. Femiano, G. Ricciardo Rizzo, F. Sica, L. Belli, R. Furlan, A. Finardi, D. Centonze, N. Modugno (Pozzilli, Italy)

    Objective: The aims of the present study were to investigate the levels of inflammatory cytokines in the cerebrospinal fluid (CSF) of drug-naïve Parkinson's Disease (PD)…
  • MDS Virtual Congress 2020

    Frequency of Wearing-Off Symptoms in Parkinson’s disease Fluctuators: An on/off evaluation

    K. Perepezko, J. Hinkle, K. Mills, G. Pontone (Baltimore, MD, USA)

    Objective: To determine if the frequency of wearing-off symptoms in Parkinson’s disease (PD) patients who report fluctuations differs from patients without fluctuations. Background: Wearing-off, the…
  • MDS Virtual Congress 2020

    Unmet psychological needs of People with Parkinson’s disease

    M. Turner, S. Chobanova, C. Grose, C. thomas, B. Mohamed (Cardiff, United Kingdom)

    Objective: To investigate whether Parkinson’s disease (PD) specialists are identifying patients with Parkinson’s psychological needs and referring them to appropriate services. Background: A number of…
  • MDS Virtual Congress 2020

    Insomnia may have a mediating role in linking Parkinson’s disease severity to depression and anxiety

    G. Yeganyan, S. Khachatryan, Z. Tavadyan (Yerevan, Armenia)

    Objective: The aim of this study was to investigate the role of insomnia in relationship of disease severity with depression/anxiety in patients with Parkinson’s disease…
  • MDS Virtual Congress 2020

    Anxiety in Parkinson’s disease is associated with changes in the brain fear circuit

    G. Carey, R. Lopes, R. Viard, N. Betrouni, G. Kuchcinski, Q. Devignes, L. Defebvre, A. Leentjens, K. Dujardin (Lille, France)

    Objective: The aim of this study was to identify the anatomical and functional changes related to anxiety, especially in the “fear circuit”, by comparing PD…
  • MDS Virtual Congress 2020

    Endophenotyping adult-onset isolated cervical dystonia: Does period of onset of mood disorder matter?

    I. Ndukwe, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: We aim to characterize clinical and demographic features pertaining to the time of onset of mood disorder in CD patients. Background: Mood disorder frequently…
  • MDS Virtual Congress 2020

    Neuroimaging of anxiety in Parkinson’s disease: a systematic review

    G. Carey, M. Görmezoğlu, K. Dujardin, A. Leentjens (Maastricht, Netherlands)

    Objective: The aim of this systematic review was 1) to identify the brain regions involved in anxiety in Parkinson's disease (PD) based on neuroimaging studies,…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 17
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley